APA (7th ed.) Citation

Kaplan, G. G., Hur, C., Korzenik, J., & Sands, B. E. (2008). Infliximab vs. Adalimumab for Crohn's disease: Authors' reply. Alimentary Pharmacology & Therapeutics, 28(10), 1266. https://doi.org/10.1111/j.1365-2036.2008.03844.x

Chicago Style (17th ed.) Citation

Kaplan, G. G., C. Hur, J. Korzenik, and B. E. Sands. "Infliximab Vs. Adalimumab for Crohn's Disease: Authors' Reply." Alimentary Pharmacology & Therapeutics 28, no. 10 (2008): 1266. https://doi.org/10.1111/j.1365-2036.2008.03844.x.

MLA (9th ed.) Citation

Kaplan, G. G., et al. "Infliximab Vs. Adalimumab for Crohn's Disease: Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 28, no. 10, 2008, p. 1266, https://doi.org/10.1111/j.1365-2036.2008.03844.x.